NCT07125274 - Sputum-free Diagnostis of TB | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Tuberculosis

Interventions

DIAGNOSTIC_TEST

Biomarker-guided diagnostic tests

mRNA-Signature from blood; immunophenotyping from blood; MBLA from sputum, PATHFAST-LAM and EclLAM from sputum, stool, urine; CRISPR-Cas from blood; stool PCR; QuantiFERON(R)-TB Gold Plus.

Trial Locations (1)

20246

RECRUITING

Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg

All Listed Sponsors

lead

Research Center Borstel

OTHER